
Harbin Pharmaceutical Group Co., Ltd.
SSE:600664.SS
3.81 (CNY) • At close June 6, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | Harbin Pharmaceutical Group Co., Ltd. |
Symbool | 600664.SS |
Munteenheid | CNY |
Prijs | 3.81 |
Beurswaarde | 9,595,523,100 |
Dividendpercentage | 0% |
52-weken bereik | 2.54 - 4.97 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Guoren Lin |
Website | https://www.hayao.com |
An error occurred while fetching data.
Over Harbin Pharmaceutical Group Co., Ltd.
Harbin Pharmaceutical Group Co., Ltd. engages in the research, development, manufacture, and trade of pharmaceuticals in China and internationally. The company operates through seven segments: Antibiotics, Small-Molecular Drug Preparations, OTC and Healthcare Products, Modern Chinese Medicines, Biopharmaceuticals, Animal Vaccines, and Medicine Circulations. It offers a series of penicillin and cephalosporin
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (CNY)
Cijfers zijn in miljoenen (CNY)